Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

Details for Australian Patent Application No. 2004257261 (hide)

Owner Arena Pharmaceuticals Inc.

Inventors Bruce, Marc A.; Jones, Robert M.; Semple, Graeme; Shin, Young-Jun; Lehmann, Juerg; Calderon, Imelda; Ren, Albert S.; Fioravanti, Beatriz; Xiong, Yifeng; Choi, Jin Sun Karoline

Agent FB Rice

Pub. Number AU-B-2004257261

PCT Pub. Number WO2005/007647

Priority 60/486,728 11.07.03 US; 60/487,370 14.07.03 US

Filing date 9 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 5 November 2009

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 239/52 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/007647 Priority application(s): WO2005/007647

5 November 2009 Application Accepted

  Published as AU-B-2004257261

4 March 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 01 Feb 2010. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

13 May 2010 Standard Patent Sealed

13 May 2010 Corrigenda

  Applications Accepted - Name Index Under the name Arena Pharmaceuticals Inc., Application No. 2004257261, under INID (71) correct the applicant name to Arena Pharmaceuticals, Inc.

22 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Feb 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257266-Compliant wheel

2004257260-Substituted heterocyclic diarylamine analogues